Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imatinib plus intensive BFM-type chemotherapy in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia
2004-001647-30Phase 3Active
- Sponsor
- Italian Association of Pediatric Hematology and Oncology
- Start
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of imatinib in acute lymphoblastic leukemia (ALL), sponsored by Italian Association of Pediatric Hematology and Oncology. Primary endpoint: Disease-free survival. Started Dec 2012; status: active.
02
Drugs
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on 2004-001647-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001647-30.